Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 10/1/18 (What's New)

Summary

  • The coformulated regimen bictegravir/emtricitabine/tenofovir AF was approved in 2018 as a complete regimen for the treatment of HIV infection in adults
    • Who are antiretroviral naive
    • As a switch regimen in those who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral regimen for ≥ 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components[FDA BIC FTC TAF]

Action required